Tina Roostaei

Affiliations: 
Tehran University of Medical Sciences, Tehran, Iran 
Google:
"Tina Roostaei"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Peroni S, Sorosina M, Malhotra S, et al. (2019) A pharmacogenetic study implicates in the response to Interferon-β in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519851428
Felsky D, Roostaei T, Nho K, et al. (2019) Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nature Communications. 10: 409
Roostaei T, Sadaghiani S, Mashhadi R, et al. (2018) Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518760715
Roostaei T, Felsky D, Nazeri A, et al. (2017) Genetic influence of plasma homocysteine on Alzheimer's disease. Neurobiology of Aging
Roostaei T, Nazeri A, Felsky D, et al. (2016) Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease. Molecular Psychiatry
Roostaei T, Sadaghiani S, Park MT, et al. (2016) Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis. Neurology
Roostaei T, Felsky D, Nazeri A, et al. (2016) Genetic Influence Of Plasma Homocysteine Level On Alzheimer'S Disease Alzheimers & Dementia. 12
Eshaghi A, Riyahi-Alam S, Saeedi R, et al. (2015) Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis. Neuroimage. Clinical. 7: 306-14
Nazeri A, Ganjgahi H, Roostaei T, et al. (2014) Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease. Neuroimage. 102: 657-65
Eshaghi A, Riyahi-Alam S, Roostaei T, et al. (2012) Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). The Clinical Neuropsychologist. 26: 975-84
See more...